|
|
|
|
|
|
|
|
|
|
Note: read the whole article "The company said it would focus its resources on developing clinical strategies for picoplatin in small cell lung cancer, as well as colorectal, prostate and ovarian cancers."
Wednesday, March 24, 2010
financial news - Picoplatin - UPDATE 3-Poniard suspends regulatory efforts on key drug | Reuters
Note: read the whole article "The company said it would focus its resources on developing clinical strategies for picoplatin in small cell lung cancer, as well as colorectal, prostate and ovarian cancers."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.